Having trouble viewing this email? View in your browser.

21 March 2017

Dear colleagues,

Submitters of late-breaking abstracts for ECCMID 2017 in Vienna have been notified yesterday. Please check your in-boxes.

Have a look at the German Society of Infectious Diseases (DGI)’s recommendations, which are part of the choosing wisely initiative. The authors of the publication include ECCMID Programme Director Winfried Kern.

Another ESCMID ad-hoc member, ESCMID Guidelines Director William Hope will lead a new Centre for Antimicrobial Pharmacodynamics (CAP) to address antimicrobial drug development challenge at the University of Liverpool. The state-of-the-art research centre, created in partnership with Liverpool School of Tropical Medicine (LSTM) and North Bristol NHS Trust, aims to help accelerate the development of new antibiotics.

You may also be interested in a recent publication by the European Respiratory Society on Anti-infectives and the Lung

The World Health Organization is setting up an interagency coordination group on antimicrobial resistance to provide practical guidance for approaches needed to ensure sustained effective global action to address antimicrobial resistance.

Your ESCMID communications editors

ESCMID Executive Office
Gerbergasse 14
4001 Basel
Phone +41 61 508 0150
Visit us on mastodon Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.